Abstract BackgroundA large number of natural products have shown in vitro antiplasmodial activities. Early identification and prioritization of these natural products with potential for novel mechanism of action, desirable pharmacokinetics and likelihood for development into drugs is advantageous. Chemo-informatic profiling of these natural products were conducted and compared to currently registered anti-malarial drugs (CRAD). MethodsNatural products with in vitro antiplasmodial activities (NAA) were compiled from various sources. These natural products were sub-divided into four groups based on inhibitory concentration (IC50). Key molecular descriptors and physicochemical properties were computed for these compounds and analysis of variance used to assess statistical significance amongst the sets of compounds. Molecular similarity analysis, estimation of drug-likeness, in silico pharmacokinetic profiling, and exploration of structure–activity landscape were also carried out on these sets of compounds. ResultsA total of 1040 natural products were selected and a total of 13 molecular descriptors were analysed. Significant differences were observed among the sub-groups of NAA and CRAD for at least 11 of the molecular descriptors, including number of hydrogen bond donors and acceptors, molecular weight, polar and hydrophobic surface areas, chiral centres, oxygen and nitrogen atoms, and shape index. The remaining molecular descriptors, including clogP, number of rotatable bonds and number of aromatic rings, did not show any significant difference when comparing the two compound sets. Molecular similarity and chemical space analysis identified natural products that were structurally diverse from CRAD. Prediction of the pharmacokinetic properties and drug-likeness of these natural products identified over 50 % with desirable drug-like properties. Nearly 70 % of all natural products were identified as potentially promiscuous compounds. Structure–activity landscape analysis highlighted compound pairs that form ‘activity cliffs’. In all, prioritization strategies for the NAA were proposed. ConclusionsChemo-informatic profiling of NAA and CRAD have produced a wealth of information that may guide decisions and facilitate anti-malarial drug development from natural products. Articulation of the information provided within an interactive data-mining environment led to a prioritized list of NAA.
data-mining         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Data_mining           

natural products              0.9999999303177016^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Natural_product       

natural products              0.9999999303177016^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Natural_product       

cliffs                        0.9999998765481527^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Cliff                 

statistical significance      1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Statistical_significance

pharmacokinetics              1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Pharmacokinetics      

natural products              0.9999999303177016^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Natural_product       

natural products              0.9999999303177016^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Natural_product       

landscape                     0.996912372746506^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/Landscape             

pharmacokinetic               1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Pharmacokinetics      

aromatic rings                1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Aromaticity           

variance                      0.9999818380134397^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Variance              

inhibitory concentration      1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/IC50                  

landscape                     0.996912372746506^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/Landscape             

drugs                         0.9999902829994501^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Drug                  

hydrophobic                   0.9984506583859398^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Hydrophobe            

NAA                           0.9999989029071564^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/North_American_Aviation

physicochemical               0.9999999999809006^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Physical_chemistry    

molecular                     0.996502244899475^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/Molecule              

molecular                     0.996502244899475^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/Molecule              

compound                      1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Chemical_compound     

molecular                     0.996502244899475^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/Molecule              

molecular weight              1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Molecular_mass        

natural products              0.9999999303177016^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Natural_product       

pharmacokinetic               1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Pharmacokinetics      

hydrogen bond                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Hydrogen_bond         

natural products              0.9999999303177016^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Natural_product       

oxygen                        0.9999027365180417^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Oxygen                

nitrogen                      0.9999999999997726^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Nitrogen              

natural products              0.9999999303177016^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Natural_product       

chiral centres                0.9999999999290594^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Chirality_(chemistry) 

compound                      1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Chemical_compound     

polar                         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Chemical_polarity     

molecular                     0.996502244899475^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/Molecule              

promiscuous                   0.9999996572130972^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Promiscuity           

NAA                           0.9999989029071564^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/North_American_Aviation

drugs                         0.9999902829994501^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Drug                  

natural products              0.9999999303177016^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Natural_product       

IC50                          1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/IC50                  

antiplasmodial                1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Plasmodium            

NAA                           0.9999989029071564^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/North_American_Aviation

chemical space                1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Chemical_space        

acceptors                     0.9999999958038188^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Electron_acceptor     

antiplasmodial                1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Plasmodium            

drug development              1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Drug_development      

NAA                           0.9999989029071564^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/North_American_Aviation

NAA                           0.9999989029071564^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/North_American_Aviation

natural products              0.9999999303177016^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Natural_product       

